aluates Reports

$ 0.0

Automative

Global and India Celecoxib Market Report & Forecast 2023-2029

Published Date: December 2023

Report Code: QYRE-Auto-29F15842

BUY CHAPTERS

Global and India Celecoxib Market Report & Forecast 2023-2029

Code: QYRE-Auto-29F15842

Report

December 2023

Pages:98

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

and India Celecoxib Market Size

The global Celecoxib revenue was US$ 1271.3 million in 2022 and is forecast to a readjusted size of US$ 2250.6 million by 2029 with a CAGR of 8.4% during the forecast period (2023-2029).

and India Celecoxib Market

Celecoxib capsules (patent brand name: CELEBREX), is a new generation of non-steroidal anti-inflammatory and analgesic drugs, mainly through the selective inhibition of coX-2 (COX-2) to inhibit the production of prostaglandins, achieve anti-inflammatory and analgesic effects.

The drug is used to relieve symptoms and signs of osteoarthritis and rheumatoid arthritis in adults and has fewer gastrointestinal side effects than traditional non-steroidal anti-inflammatory drugs.

In India, the Celecoxib revenue is expected to grow from US$ million in 2022 to US$ million by 2029, at a CAGR of % during the forecast period (2023-2029).

Data show that more than 400 million people worldwide are currently affected by joint diseases.

The prevalence of osteoarthritis is 17 percent among people aged 40, 62 percent among people over 60 and 80 percent among people over 75.

The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing.

At present, the burden of chronic diseases will increase by 40% due to the aging of the population.

As the population ages, anti-inflammatory and anti-rheumatic drugs will enter a phase of rapid growth.

Globally, whether prescription drugs or non-prescription drugs, Xibu is widely used in clinical practice.

At present, the best seller in the international market is Celixib. Celixib market will continue to grow steadily in the next few years.

At present, the global Celecoxib market is basically occupied by Pfizer, which has formed an oligopoly.

It accounted for 63.39% of the global market in 2019.

As of 2019, China relies entirely on Pfizer for celecoxib imports.

Since 2020, some domestic drug companies have been gradually approved by FDA and CFDA. The introduction of celecoxib generic drugs by local companies will break the monopoly of import.

This report focuses on global and India Celecoxib market, also covers the segmentation data of other regions in regional level and county level.

India is now the world’s most populous country. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment. First and foremost, the key factor in India's rapid economic growth is the huge supply and demand from a large population base. Demand and supply sides working in both directions to support India's economic stability.

India is a market full of opportunities, and the demand for Celecoxib will continue to grow rapidly in the future.

Global Celecoxib Scope and Market Size

Celecoxib market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Celecoxib market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2029.

For India market, this report focuses on the Celecoxib market size by players, by Type and by Application, for the period 2018-2029. The key players include the global and local players, which play important roles in India.

Scope of and India Celecoxib Market Report

Report Metric	Details
Report Name	and India Celecoxib Market
Forecasted market size in 2029	US$ 2250.6 million
CAGR	8.4%
Forecasted years	2023 - 2029
Segment by Type	50mg 100mg 200mg 400mg
Segment by Application	Rheumatoid arthritis osteoarthritis Acute pain Musculoskeletal pain Other diseases
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Pfizer Inc, Teva, Mylan, Apotex, Lupin, Hengrui Medicine
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

What is the and India Celecoxib Market size in 2029?

Ans: The and India Celecoxib Market size in 2029 will be US$ 2250.6 million.

What is the and India Celecoxib Market share by region?

Ans: The number of patients with arthritis in mainland China is more than 10% of the total population, well over 100 million, and the incidence of arthritis increases with age, and the number of patients is still increasing. According to IMF (its July update to its World Economic Outlook), India’s GDP growth is projected at 6.1% in 2023, powered by domestic investment.

Who are the main players in the and India Celecoxib Market report?

Ans: The main players in the and India Celecoxib Market are Pfizer Inc, Teva, Mylan, Apotex, Lupin, Hengrui Medicine

What are the Application segmentation covered in the and India Celecoxib Market report?

Ans: The Applications covered in the and India Celecoxib Market report are Rheumatoid arthritis, osteoarthritis, Acute pain, Musculoskeletal pain, Other diseases

What are the Type segmentation covered in the and India Celecoxib Market report?

Ans: The Types covered in the and India Celecoxib Market report are 50mg, 100mg, 200mg, 400mg

Recommended Reports

Pain Relief Drugs

Arthritis & Osteoarthritis

Anti-inflammatory Drugs

1 Study Coverage

1.1 Celecoxib Product Introduction

1.2 Global Celecoxib Outlook 2018 VS 2022 VS 2029

1.2.1 Global Celecoxib Sales in US$ Million for the Year 2018-2029

1.2.2 Global Celecoxib Sales in Volume for the Year 2018-2029

1.3 India Celecoxib Outlook 2018 VS 2022 VS 2029

1.3.1 India Celecoxib Sales in US$ Million for the Year 2018-2029

1.3.2 India Celecoxib Sales in Volume for the Year 2018-2029

1.4 Celecoxib Market Size, India VS Global, 2018 VS 2022 VS 2029

1.4.1 The Market Share of India Celecoxib in Global, 2018 VS 2022 VS 2029

1.4.2 The Growth Rate of Celecoxib Market Size, India VS Global, 2018 VS 2022 VS 2029

1.5 Celecoxib Market Dynamics

1.5.1 Celecoxib Industry Trends

1.5.2 Celecoxib Market Drivers

1.5.3 Celecoxib Market Challenges

1.5.4 Celecoxib Market Restraints

1.6 Study Objectives

1.7 Years Considered

1.8 Years Considered

2 Celecoxib by Type

2.1 Celecoxib Market Segment by Type

2.1.1 50mg

2.1.2 100mg

2.1.3 200mg

2.1.4 400mg

2.2 Global Celecoxib Market Size by Type

2.2.1 Global Celecoxib Sales in Value, by Type (2018, 2022 & 2029)

2.2.2 Global Celecoxib Sales in Volume, by Type (2018, 2022 & 2029)

2.2.3 Global Celecoxib Average Selling Price (ASP) by Type (2018, 2022 & 2029)

2.3 India Celecoxib Market Size by Type

2.3.1 India Celecoxib Sales in Value, by Type (2018, 2022 & 2029)

2.3.2 India Celecoxib Sales in Volume, by Type (2018, 2022 & 2029)

2.3.3 India Celecoxib Average Selling Price (ASP) by Type (2018, 2022 & 2029)

3 Celecoxib by Application

3.1 Celecoxib Market Segment by Application

3.1.1 Rheumatoid arthritis

3.1.2 osteoarthritis

3.1.3 Acute pain

3.1.4 Musculoskeletal pain

3.1.5 Other diseases

3.2 Global Celecoxib Market Size by Application

3.2.1 Global Celecoxib Sales in Value, by Application (2018, 2022 & 2029)

3.2.2 Global Celecoxib Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 Global Celecoxib Average Selling Price (ASP) by Application (2018, 2022 & 2029)

3.3 India Celecoxib Market Size by Application

3.3.1 India Celecoxib Sales in Value, by Application (2018, 2022 & 2029)

3.3.2 India Celecoxib Sales in Volume, by Application (2018, 2022 & 2029)

3.3.3 India Celecoxib Average Selling Price (ASP) by Application (2018, 2022 & 2029)

4 Global Celecoxib Competitor Landscape by Company

4.1 Global Celecoxib Market Size by Company

4.1.1 Global Key Manufacturers of Celecoxib, Ranked by Revenue (2022)

4.1.2 Global Celecoxib Revenue by Manufacturer (2018-2023)

4.1.3 Global Celecoxib Sales by Manufacturer (2018-2023)

4.1.4 Global Celecoxib Price by Manufacturer (2018-2023)

4.2 Global Celecoxib Concentration Ratio (CR)

4.2.1 Celecoxib Market Concentration Ratio (CR)

4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Celecoxib in 2022

4.2.3 Global Celecoxib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.3 Global Key Manufacturers of Celecoxib, Manufacturing Base Distribution and Headquarters

4.4 Global Key Manufacturers of Celecoxib, Product Offered and Application

4.5 Global Key Manufacturers of Celecoxib, Date of Enter into This Industry

4.6 Manufacturers Mergers & Acquisitions, Expansion Plans

4.7 India Celecoxib Market Size by Company

4.7.1 Key Players of Celecoxib in India, Ranked by Revenue (2022)

4.7.2 India Celecoxib Revenue by Players (2018-2023)

4.7.3 India Celecoxib Sales by Players (2018-2023)

5 Global Celecoxib Market Size by Region

5.1 Global Celecoxib Market Size by Region: 2018 VS 2022 VS 2029

5.2 Global Celecoxib Market Size in Volume by Region (2018-2029)

5.2.1 Global Celecoxib Sales in Volume by Region: 2018-2023

5.2.2 Global Celecoxib Sales in Volume Forecast by Region (2024-2029)

5.3 Global Celecoxib Market Size in Value by Region (2018-2029)

5.3.1 Global Celecoxib Sales in Value by Region: 2018-2023

5.3.2 Global Celecoxib Sales in Value by Region: 2024-2029

6 Americas

6.1 Americas Celecoxib Market Size YoY Growth 2018-2029

6.2 Americas Celecoxib Sales in Volume, by Type (2018, 2022 & 2029)

6.3 Americas Celecoxib Sales in Volume, by Application (2018, 2022 & 2029)

6.4 Americas Celecoxib Market Facts & Figures by Country (2018, 2022 & 2029)

6.4.1 Americas Celecoxib Sales in Value by Country (2018, 2022 & 2029)

6.4.2 Americas Celecoxib Sales in Volume by Country (2018, 2022 & 2029)

6.4.3 United States

6.4.4 Canada

6.4.5 Mexico

6.4.6 Brazil

7 EMEA

7.1 EMEA Celecoxib Market Size YoY Growth 2018-2029

7.2 EMEA Celecoxib Sales in Volume, by Type (2018, 2022 & 2029)

7.3 EMEA Celecoxib Sales in Volume, by Application (2018, 2022 & 2029)

7.4 EMEA Celecoxib Market Facts & Figures by Country (2018, 2022 & 2029)

7.4.1 EMEA Celecoxib Sales in Value by Country (2018, 2022 & 2029)

7.4.2 EMEA Celecoxib Sales in Volume by Country (2018, 2022 & 2029)

7.4.3 Europe

7.4.4 Middle East

7.4.5 Africa

8 China

8.1 China Celecoxib Market Size YoY Growth 2018-2029

8.2 China Celecoxib Sales in Volume, by Type (2018, 2022 & 2029)

8.3 China Celecoxib Sales in Volume, by Application (2018, 2022 & 2029)

9 APAC

9.1 APAC Celecoxib Market Size YoY Growth 2018-2029

9.2 APAC Celecoxib Sales in Volume, by Type (2018, 2022 & 2029)

9.3 APAC Celecoxib Sales in Volume, by Application (2018, 2022 & 2029)

9.4 APAC Celecoxib Market Facts & Figures by Region (2018, 2022 & 2029)

9.4.1 APAC Celecoxib Sales in Value by Region (2018, 2022 & 2029)

9.4.2 APAC Celecoxib Sales in Volume by Region (2018, 2022 & 2029)

9.4.3 Japan

9.4.4 South Korea

9.4.5 China Taiwan

9.4.6 Southeast Asia

9.4.7 India

10 Company Profiles

10.1 Pfizer Inc

10.1.1 Pfizer Inc Company Information

10.1.2 Pfizer Inc Description and Business Overview

10.1.3 Pfizer Inc Celecoxib Sales, Revenue and Gross Margin (2018-2023)

10.1.4 Pfizer Inc Celecoxib Products Offered

10.1.5 Pfizer Inc Recent Development

10.2 Teva

10.2.1 Teva Company Information

10.2.2 Teva Description and Business Overview

10.2.3 Teva Celecoxib Sales, Revenue and Gross Margin (2018-2023)

10.2.4 Teva Celecoxib Products Offered

10.2.5 Teva Recent Development

10.3 Mylan

10.3.1 Mylan Company Information

10.3.2 Mylan Description and Business Overview

10.3.3 Mylan Celecoxib Sales, Revenue and Gross Margin (2018-2023)

10.3.4 Mylan Celecoxib Products Offered

10.3.5 Mylan Recent Development

10.4 Apotex

10.4.1 Apotex Company Information

10.4.2 Apotex Description and Business Overview

10.4.3 Apotex Celecoxib Sales, Revenue and Gross Margin (2018-2023)

10.4.4 Apotex Celecoxib Products Offered

10.4.5 Apotex Recent Development

10.5 Lupin

10.5.1 Lupin Company Information

10.5.2 Lupin Description and Business Overview

10.5.3 Lupin Celecoxib Sales, Revenue and Gross Margin (2018-2023)

10.5.4 Lupin Celecoxib Products Offered

10.5.5 Lupin Recent Development

10.6 Hengrui Medicine

10.6.1 Hengrui Medicine Company Information

10.6.2 Hengrui Medicine Description and Business Overview

10.6.3 Hengrui Medicine Celecoxib Sales, Revenue and Gross Margin (2018-2023)

10.6.4 Hengrui Medicine Celecoxib Products Offered

10.6.5 Hengrui Medicine Recent Development

11 Industry Chain and Sales Channels Analysis

11.1 Celecoxib Industry Chain Analysis

11.2 Celecoxib Key Raw Materials

11.2.1 Key Raw Materials

11.2.2 Raw Materials Key Suppliers

11.3 Celecoxib Production Mode & Process

11.4 Celecoxib Sales and Marketing

11.4.1 Celecoxib Sales Channels

11.4.2 Celecoxib Distributors

11.5 Celecoxib Customers

12 Research Findings and Conclusion

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

List of Tables

Table 1. Celecoxib CAGR in Value, India VS Global, 2018 VS 2022 VS 2029

Table 2. Celecoxib Market Trends

Table 3. Celecoxib Market Drivers

Table 4. Celecoxib Market Challenges

Table 5. Celecoxib Market Restraints

Table 6. Global Celecoxib Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 7. India Celecoxib Sales Growth Rate (CAGR) by Type: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Celecoxib Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 9. India Celecoxib Sales Growth Rate (CAGR) by Application: 2018 VS 2022 VS 2029 (US$ Million)

Table 10. Global Key Manufacturers of Celecoxib, Ranked by Revenue (2022) & (US$ Million)

Table 11. Global Celecoxib Revenue by Manufacturer, (US$ Million), 2018-2023

Table 12. Global Celecoxib Revenue Share by Manufacturer, 2018-2023

Table 13. Global Celecoxib Sales by Manufacturer, (K Units), 2018-2023

Table 14. Global Celecoxib Sales Share by Manufacturer, 2018-2023

Table 15. Global Celecoxib Price by Manufacturer (2018-2023) & (US$/Unit)

Table 16. Global Celecoxib Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 17. Global Celecoxib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Celecoxib as of 2022)

Table 18. Global Key Manufacturers of Celecoxib, Manufacturing Base Distribution and Headquarters

Table 19. Global Key Manufacturers of Celecoxib, Product Offered and Application

Table 20. Global Key Manufacturers of Celecoxib, Date of Enter into This Industry

Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 22. Key Players of Celecoxib in India, Ranked by Revenue (2022) & (US$ million)

Table 23. India Celecoxib Revenue by Players, (US$ Million), (2018-2023)

Table 24. India Celecoxib Revenue Share by Players, (2018-2023)

Table 25. India Celecoxib Sales by Players, (K Units), (2018-2023)

Table 26. India Celecoxib Sales Share by Players, (2018-2023)

Table 27. Global Celecoxib Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 28. Global Celecoxib Sales in Volume by Region (2018-2023) & (K Units)

Table 29. Global Celecoxib Sales in Volume Forecast by Region (2024-2029) & (K Units)

Table 30. Global Celecoxib Sales in Value by Region (2018-2023) & (US$ Million)

Table 31. Global Celecoxib Sales in Value Forecast by Region (2024-2029) & (US$ Million)

Table 32. Americas Celecoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 33. Americas Celecoxib Sales in Value by Country (2018-2023) & (US$ Million)

Table 34. Americas Celecoxib Sales in Value by Country (2024-2029) & (US$ Million)

Table 35. Americas Celecoxib Sales in Volume by Country (2018-2023) & (K Units)

Table 36. Americas Celecoxib Sales in Volume by Country (2024-2029) & (K Units)

Table 37. EMEA Celecoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 38. EMEA Celecoxib Sales in Value by Country (2018-2023) & (US$ Million)

Table 39. EMEA Celecoxib Sales in Value by Country (2024-2029) & (US$ Million)

Table 40. EMEA Celecoxib Sales in Volume by Country (2018-2023) & (K Units)

Table 41. EMEA Celecoxib Sales in Volume by Country (2024-2029) & (K Units)

Table 42. APAC Celecoxib Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029

Table 43. APAC Celecoxib Sales in Value by Country (2018-2023) & (US$ Million)

Table 44. APAC Celecoxib Sales in Value by Country (2024-2029) & (US$ Million)

Table 45. APAC Celecoxib Sales in Volume by Country (2018-2023) & (K Units)

Table 46. APAC Celecoxib Sales in Volume by Country (2024-2029) & (K Units)

Table 47. Pfizer Inc Company Information

Table 48. Pfizer Inc Description and Business Overview

Table 49. Pfizer Inc Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 50. Pfizer Inc Celecoxib Product

Table 51. Pfizer Inc Recent Development

Table 52. Teva Company Information

Table 53. Teva Description and Business Overview

Table 54. Teva Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 55. Teva Celecoxib Product

Table 56. Teva Recent Development

Table 57. Mylan Company Information

Table 58. Mylan Description and Business Overview

Table 59. Mylan Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 60. Mylan Celecoxib Product

Table 61. Mylan Recent Development

Table 62. Apotex Company Information

Table 63. Apotex Description and Business Overview

Table 64. Apotex Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 65. Apotex Celecoxib Product

Table 66. Apotex Recent Development

Table 67. Lupin Company Information

Table 68. Lupin Description and Business Overview

Table 69. Lupin Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 70. Lupin Celecoxib Product

Table 71. Lupin Recent Development

Table 72. Hengrui Medicine Company Information

Table 73. Hengrui Medicine Description and Business Overview

Table 74. Hengrui Medicine Celecoxib Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

Table 75. Hengrui Medicine Celecoxib Product

Table 76. Hengrui Medicine Recent Development

Table 77. Key Raw Materials Lists

Table 78. Raw Materials Key Suppliers Lists

Table 79. Celecoxib Customers List

Table 80. Celecoxib Distributors List

Table 81. Research Programs/Design for This Report

Table 82. Key Data Information from Secondary Sources

Table 83. Key Data Information from Primary Sources

List of Figures

Figure 1. Celecoxib Product Picture

Figure 2. Global Celecoxib Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Celecoxib Market Size 2018-2029 (US$ Million)

Figure 4. Global Celecoxib Sales 2018-2029 (K Units)

Figure 5. India Celecoxib Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 6. India Celecoxib Market Size 2018-2029 (US$ Million)

Figure 7. India Celecoxib Sales 2018-2029 (K Units)

Figure 8. India Celecoxib Market Share in Global, in Value (US$ Million) 2018-2029

Figure 9. India Celecoxib Market Share in Global, in Volume (K Units) 2018-2029

Figure 10. Celecoxib Report Years Considered

Figure 11. Product Picture of 50mg

Figure 12. Product Picture of 100mg

Figure 13. Product Picture of 200mg

Figure 14. Product Picture of 400mg

Figure 15. Global Celecoxib Market Share by Type in 2022 & 2029

Figure 16. Global Celecoxib Sales in Value by Type (2018-2029) & (US$ Million)

Figure 17. Global Celecoxib Sales Market Share in Value by Type (2018-2029)

Figure 18. Global Celecoxib Sales by Type (2018-2029) & (K Units)

Figure 19. Global Celecoxib Sales Market Share in Volume by Type (2018-2029)

Figure 20. Global Celecoxib Price by Type (2018-2029) & (US$/Unit)

Figure 21. India Celecoxib Market Share by Type in 2022 & 2029

Figure 22. India Celecoxib Sales in Value by Type (2018-2029) & (US$ Million)

Figure 23. India Celecoxib Sales Market Share in Value by Type (2018-2029)

Figure 24. India Celecoxib Sales by Type (2018-2029) & (K Units)

Figure 25. India Celecoxib Sales Market Share in Volume by Type (2018-2029)

Figure 26. India Celecoxib Price by Type (2018-2029) & (US$/Unit)

Figure 27. Product Picture of Rheumatoid arthritis

Figure 28. Product Picture of osteoarthritis

Figure 29. Product Picture of Acute pain

Figure 30. Product Picture of Musculoskeletal pain

Figure 31. Product Picture of Other diseases

Figure 32. Global Celecoxib Market Share by Application in 2022 & 2029

Figure 33. Global Celecoxib Sales in Value by Application (2018-2029) & (US$ Million)

Figure 34. Global Celecoxib Sales Market Share in Value by Application (2018-2029)

Figure 35. Global Celecoxib Sales by Application (2018-2029) & (K Units)

Figure 36. Global Celecoxib Sales Market Share in Volume by Application (2018-2029)

Figure 37. Global Celecoxib Price by Application (2018-2029) & (US$/Unit)

Figure 38. India Celecoxib Market Share by Application in 2022 & 2029

Figure 39. India Celecoxib Sales in Value by Application (2018-2029) & (US$ Million)

Figure 40. India Celecoxib Sales Market Share in Value by Application (2018-2029)

Figure 41. India Celecoxib Sales by Application (2018-2029) & (K Units)

Figure 42. India Celecoxib Sales Market Share in Volume by Application (2018-2029)

Figure 43. India Celecoxib Price by Application (2018-2029) & (US$/Unit)

Figure 44. Americas Celecoxib Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 45. Americas Celecoxib Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 46. Americas Celecoxib Sales by Type (2018-2029) & (K Units)

Figure 47. Americas Celecoxib Sales Market Share in Volume by Type (2018-2029)

Figure 48. Americas Celecoxib Sales by Application (2018-2029) & (K Units)

Figure 49. Americas Celecoxib Sales Market Share in Volume by Application (2018-2029)

Figure 50. United States Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 51. Canada Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 52. Mexico Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 53. Brazil Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 54. EMEA Celecoxib Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 55. EMEA Celecoxib Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 56. EMEA Celecoxib Sales by Type (2018-2029) & (K Units)

Figure 57. EMEA Celecoxib Sales Market Share in Volume by Type (2018-2029)

Figure 58. EMEA Celecoxib Sales by Application (2018-2029) & (K Units)

Figure 59. EMEA Celecoxib Sales Market Share in Volume by Application (2018-2029)

Figure 60. Europe Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 61. Middle East Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 62. Africa Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 63. China Celecoxib Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 64. China Celecoxib Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 65. China Celecoxib Sales by Type (2018-2029) & (K Units)

Figure 66. China Celecoxib Sales Market Share in Volume by Type (2018-2029)

Figure 67. China Celecoxib Sales by Application (2018-2029) & (K Units)

Figure 68. China Celecoxib Sales Market Share in Volume by Application (2018-2029)

Figure 69. APAC Celecoxib Sales in Volume Growth Rate 2018-2029 (K Units)

Figure 70. APAC Celecoxib Sales in Value Growth Rate 2018-2029 (US$ Million)

Figure 71. APAC Celecoxib Sales by Type (2018-2029) & (K Units)

Figure 72. APAC Celecoxib Sales Market Share in Volume by Type (2018-2029)

Figure 73. APAC Celecoxib Sales by Application (2018-2029) & (K Units)

Figure 74. APAC Celecoxib Sales Market Share in Volume by Application (2018-2029)

Figure 75. Japan Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 76. South Korea Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 77. China Taiwan Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 78. Southeast Asia Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 79. India Celecoxib Sales in Value Growth Rate (2018-2029) & (US$ Million)

Figure 80. Celecoxib Value Chain

Figure 81. Celecoxib Production Process

Figure 82. Channels of Distribution

Figure 83. Distributors Profiles

Figure 84. Bottom-up and Top-down Approaches for This Report

Figure 85. Data Triangulation

Figure 86. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$6525

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$8700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions